APA

Verstovsek S., Kantarjian H., Estey E., Aguayo A., Giles F. J., Manshouri T., Koller C., Estrov Z., Freireich E., Keating M. & Albitar M. (20010816). Plasma hepatocyte growth factor is a prognostic factor in patients with acute myeloid leukemia but not in patients with myelodysplastic syndrome. : Leukemia.

Chicago

Verstovsek S, Kantarjian H, Estey E, Aguayo A, Giles F J, Manshouri T, Koller C, Estrov Z, Freireich E, Keating M and Albitar M. 20010816. Plasma hepatocyte growth factor is a prognostic factor in patients with acute myeloid leukemia but not in patients with myelodysplastic syndrome. : Leukemia.

Harvard

Verstovsek S., Kantarjian H., Estey E., Aguayo A., Giles F. J., Manshouri T., Koller C., Estrov Z., Freireich E., Keating M. and Albitar M. (20010816). Plasma hepatocyte growth factor is a prognostic factor in patients with acute myeloid leukemia but not in patients with myelodysplastic syndrome. : Leukemia.

MLA

Verstovsek S, Kantarjian H, Estey E, Aguayo A, Giles F J, Manshouri T, Koller C, Estrov Z, Freireich E, Keating M and Albitar M. Plasma hepatocyte growth factor is a prognostic factor in patients with acute myeloid leukemia but not in patients with myelodysplastic syndrome. : Leukemia. 20010816.